ORCID : 0000-0001-8656-5755

  1. Wang, R. H., P.-R. Chen, Y.-T. Chen, Y.-C. Chen, Y.-H. Chu, C.-C. Chien, P.-C. Chien, S.-Y. Lo, Z.-L. Wang, M.-C. Tsou, S.-Y. Chen, G.-S. Chiu, W.-L. Chen, Y.-H. Wu, L. H.-C. Wang, W.-C. Wang, S.-Y. Lin, H.-J. Kung, *L.-H. Wang, *H.-C. Cheng and *Lin, K. T. “Hydrogen Sulfide Coordinates Glucose Metabolism Switch through Destabilizing Tetrameric Pyruvate Kinase M2. Nature Communications. 2024. 15, 7463. (*Corresponding Author)
  2. Yeh, H. W., P. P. Chen, T. C. Yeh, S. L. Lin, Y. T. Chen, W. P. Lin, T. Chen, J. M. Pang, *K. T. Lin, L. H. Wang, Y. C. Lin, O. Shih, U. S. Jeng, K. C. Hsia, and H. C. Cheng. 2024. Cep57 regulates human centrosomes through multivalent interactions, Proc Natl Acad Sci U S A, 2024. 121: e2305260121.
  3. Pang, J. M., Chien, P. C., Kao, M. C., Chiu, P. Y., Chen, P. X., Hsu, Y. L., Liu, C, Liang, X, and *Lin, K. T., MicroRNA-708 emerges as a potential candidate to target undruggable NRAS. PLoS One. 2023. e0284744. (*Corresponding author)
  4. Chu, Y. H., Huang, Y. C., Chiu, P. Y., Kuo, W. H., Pan, Y. R., Kuo, Y. T, Wang, R. H., Kao, Y. C., Wang, Y. H., Lin, Y. F., and *Lin, K. T., Combating breast cancer progression through combination therapy with hypomethylating agent and glucocorticoid. iScience. 2023. 26: 106597. (*Corresponding author)
  5. Alias, A.B.; *Huang, H.-Y.; Wang, Y.-W.; *Lin, K. T.; Lu, P.-J.; Wu, T.-H.; Jiang, P.-S.; Chen, C.-A.; *Yao, D.-J. DNA Sequencing from Subcritical Concentration of Cell-Free DNA Extracted from Electrowetting-on-Dielectric Platform. Micromachines 2022. 13: 507 (*Corresponding author)
  6. Ma YK, Zeng PY, Chu YH, Lee CL, Cheng CC, Chen CH, Su, Y. S. *Lin, K. T., Kuo, T. H. Lack of social touch alters anxiety-like and social behaviors in male mice. Stress. 2022. 25(1):134-44.
  7. Chen T, Yeh H.W., Chen P.P., Huang W.T., Wu C.Y., Liao T.C., Lin S.L., Chen Y.Y., *Lin K.T., Hsu S.T.D, Cheng H.C. BARD1 is an ATPase activating protein for OLA1. Biochimica et Biophysica Acta – General Subjects. 2022. Online, 130099
  8. Wang, Y. H., Shen, C. Y., Lin, S. C., Kuo, W. H., Kuo, Y. T., Hsu, Y. L., Wang, W. C., *Lin, K. T., *Wang., L. H., Monocytes secrete CXCL7 to promote breast cancer progression. Cell Death & Disease. 2021. 12. 1090 (*Corresponding author).
  9. Wang, R. H., Chu, Y. H., *Lin, K. T. The Hidden Role of Hydrogen Sulfide Metabolism in Cancer. Int. J. Mol. Sci. 2021. 22: 6562. (Review)
  10. Pang, J. M., Huang, Y. C., Sun, S. P., Pan, Y. R., Shen, C. Y., Kao, M. C., Wang, R. H., Wang, L. H., and *Lin, K. T. Effects of synthetic glucocorticoids on breast cancer metastasis. Steroids. 2020. 164, 108738 (*Corresponding author).
  11. Chiang, C. E., Huang, H. Y., *Lin, K. T., Alias, A. B., Lu, P. J., Wang, Y. W., Wu, T. H., Jiang, P. H., Chen, C. A., and Yao, D. J. A medical innovation: a new and improved method of DNA extraction with electrowetting-on-dielectric of genetic testing in vitro fertilization (IVF). Microfluidics and Nanofluidics. 2020. 24 (7), 1-9
  12. Alias, A. B., Chiang, C. E., Huang, H. Y., Wang, Y. W., *Lin, K. T., Lu, P. J., Wu, T. H., Jiang, P. H., Chen, C. A., and Yao, D. J. Extraction of cell-free DNA from an embryo-culture medium using micro-scale bio-reagents on EWOD. Scientific Reports. 2020. 10 (1), 1-9
  13. Wang, Y. H., Huang, J. T., Chen, W. L., Wang, R. H., Kao, M., C., Pan, Y. R., Chan, S. H., Tsai, K. W., Kung, H. J., *Lin, K. T., and Wang, L. H.* Dysregulation of cystathionine γ-lyase promotes prostate cancer progression and metastasis. EMBO Reports. 2019, e45986. (*Corresponding author)
  14. Chang, J.W., Kuo, W.H., Lin, C.M., Chen, W.L., Chan, S.H., Chiu, M.F., Chang, I.S., Jiang, S.S., Tsai, F.Y., Chen, C.H., Huang, P.H., Chang, K.J., *Lin, K.T., Lin, S.C., Wang, M.Y., Uen, Y.H., Tu, C.W., Hou, M.F., Tsai, S.F., Shen, C.Y., Tung, S.L. and Wang, L.H. Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7–CYFIP1-mediated signaling pathway. Oncogene 2018. 37(30): 4137-4150.
  15. *Lin, K. T., Sun, S. P., Jui-I Wu, and Wang, L-H. Low dose glucocorticoids administration induces miRNA-708 to suppress ovarian cancer metastasis in an immune competent syngeneic mouse model. PLOS ONE. 2017. 12(6): e0178937.
  16. *Lin, K. T., Wang, L-H. New dimension of glucocorticoids in cancer treatment. Steroids. 2016. 111:84-88 (Invited review)
  17. *Lin, K.T., Yeh, Y.M., Chuang, C.M., Yang, S.Y., Chang, J.W., Sun, S.P., Wang, Y.S., Chao, K.C., and Wang, L-H. Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B. Nature Communications. 2015. 6:5917.
  18. *Lin, K.T., Gong, J, Li, J. F., Jang, T. H., Chen, W. L., Chen, H. J., and Wang, L-H. 2012. Vav3-Rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence. Cancer Research. 2012. 72:3000-3009.
  19. Schlosshauer, P.W., Li, W., *Lin, K.T., Chan, J. L-K., and Wang, L.-H. Rapamycin by itself and additively in combination with carboplatin inhibits the growth of ovarian cancer cells. Gynecologic Oncology. 2009. 114:516-522.
  20. *Lin, K.T., Sloniowski S., Ethell, D.W., and Ethell, I.M. Ephrin-B2 induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion. J. Biol. Chem. 2008. 283:28969-79.
  21. *Lin, K.T., Lu, R.M., and Tarn, W.Y. The WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivo. Mol. Cell Biol. 2004. 24:9176-85.